PDB Short entry for 3DJ5 HEADER TRANSFERASE 22-JUN-08 3DJ5 TITLE CRYSTAL STRUCTURE OF THE MOUSE AURORA-A CATALYTIC DOMAIN (ASN186->GLY, TITLE 2 LYS240->ARG, MET302->LEU) IN COMPLEX WITH COMPOUND 290. COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE KINASE 6; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: AURORA A KINASE DOMAIN, UNP RESIDUES 116-382; COMPND 5 SYNONYM: AURORA-A KINASE; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: AURKA, STK6; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) STAR CODON+; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGEX6P-1 KEYWDS AURORA A, SMALL-MOLECULE INHIBITOR, FRAGMENT-BASED DRUG DISCOVERY, KEYWDS 2 KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR R.A.ELLING,D.A.ERLANSON,W.YANG,B.T.TANGONAN,S.K.HANSEN,M.J.ROMANOWSKI REVDAT 4 30-AUG-23 3DJ5 1 REMARK REVDAT 3 20-OCT-21 3DJ5 1 REMARK SEQADV REVDAT 2 24-JAN-18 3DJ5 1 AUTHOR REVDAT 1 05-MAY-09 3DJ5 0 JRNL AUTH R.A.ELLING,D.A ERLANSON,W.YANG,B.T.TANGONAN,S.K.HANSEN, JRNL AUTH 2 M.J.ROMANOWSKI JRNL TITL NEW FRAGMENT-BASED DRUG DISCOVERY JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 29178 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.210 REMARK 3 R VALUE (WORKING SET) : 0.207 REMARK 3 FREE R VALUE : 0.243 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.700 REMARK 3 FREE R VALUE TEST SET COUNT : 2449 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 15 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.86 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2844 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.36 REMARK 3 BIN R VALUE (WORKING SET) : 0.3030 REMARK 3 BIN FREE R VALUE SET COUNT : 248 REMARK 3 BIN FREE R VALUE : 0.3960 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2077 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 31 REMARK 3 SOLVENT ATOMS : 369 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.48 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.50000 REMARK 3 B22 (A**2) : 0.50000 REMARK 3 B33 (A**2) : -0.76000 REMARK 3 B12 (A**2) : 0.25000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.138 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.132 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.087 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.744 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.950 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.932 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2160 ; 0.009 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2920 ; 1.166 ; 1.977 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 250 ; 5.152 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 106 ;33.545 ;22.642 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 376 ;15.266 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 20 ;21.574 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 313 ; 0.079 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1647 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1038 ; 0.197 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1432 ; 0.300 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 233 ; 0.142 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 75 ; 0.185 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 34 ; 0.146 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1302 ; 2.642 ; 2.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2022 ; 3.682 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 994 ; 3.465 ; 2.500 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 898 ; 4.906 ; 5.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3DJ5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 25-JUN-08. REMARK 100 THE DEPOSITION ID IS D_1000048102. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-APR-08 REMARK 200 TEMPERATURE (KELVIN) : 160 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL7-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : SINGLE CRYSTAL (SI111) BENT REMARK 200 MONOCHROMATOR (HORIZONTAL REMARK 200 FOCUSING) REMARK 200 OPTICS : VERTICAL FOCUSING MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSTALCLEAR REMARK 200 DATA SCALING SOFTWARE : D*TREK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31664 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : 0.05300 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 16.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.16700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 2C6D REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.77 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.72 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN AT 8.5 MG/ML IN 50 MM TRIS PH REMARK 280 7.0, 200 MM NACL, 3 MM DTT; HANGING-DROP VAPOR DIFFUSION; MOTHER REMARK 280 LIQUOR: 0.1 M SODIUM CITRATE TRIBASIC DIHYDRATE PH 5.6, 2% REMARK 280 TACSIMATE, 16% PEG 3350; TEMPERATURE: 293K; CRYOPROTECTANT: 20% REMARK 280 GLYCEROL; CRYSTAL FROZEN BY IMMERSION IN LIQUID NITROGEN REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 41.48267 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 20.74133 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 20.74133 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 41.48267 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4470 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24370 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -27.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 20.74133 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 408 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 606 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 133 REMARK 465 PRO A 134 REMARK 465 LEU A 135 REMARK 465 GLY A 136 REMARK 465 SER A 137 REMARK 465 LYS A 138 REMARK 465 ARG A 139 REMARK 465 GLN A 140 REMARK 465 SER A 291 REMARK 465 VAL A 292 REMARK 465 HIS A 293 REMARK 465 ALA A 294 REMARK 465 PRO A 295 REMARK 465 SER A 296 REMARK 465 SER A 297 REMARK 465 ARG A 298 REMARK 465 ARG A 299 REMARK 465 LYS A 402 REMARK 465 PRO A 403 REMARK 465 SER A 404 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 215 -160.22 -128.07 REMARK 500 SER A 239 -49.02 75.76 REMARK 500 ASP A 269 90.46 -166.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AK5 A 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3D14 RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH INHIBITOR AK1 REMARK 900 RELATED ID: 3D15 RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH INHIBITOR AK2 REMARK 900 RELATED ID: 3D2I RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH INHIBITOR AK3 REMARK 900 RELATED ID: 3D2K RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH INHIBITOR AK4 REMARK 900 RELATED ID: 2C6D RELATED DB: PDB REMARK 900 AURORA A KINASE ACTIVATED MUTANT (T287D) IN COMPLEX WITH ADPNP REMARK 900 RELATED ID: 3DJ6 RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH INHIBITOR AK6 REMARK 900 RELATED ID: 3DJ7 RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH INHIBITOR AK7 DBREF 3DJ5 A 138 404 UNP Q8C3H8 Q8C3H8_MOUSE 116 382 SEQADV 3DJ5 GLY A 133 UNP Q8C3H8 EXPRESSION TAG SEQADV 3DJ5 PRO A 134 UNP Q8C3H8 EXPRESSION TAG SEQADV 3DJ5 LEU A 135 UNP Q8C3H8 EXPRESSION TAG SEQADV 3DJ5 GLY A 136 UNP Q8C3H8 EXPRESSION TAG SEQADV 3DJ5 SER A 137 UNP Q8C3H8 EXPRESSION TAG SEQADV 3DJ5 GLY A 186 UNP Q8C3H8 ASN 164 ENGINEERED MUTATION SEQADV 3DJ5 ARG A 240 UNP Q8C3H8 LYS 218 ENGINEERED MUTATION SEQADV 3DJ5 LEU A 302 UNP Q8C3H8 MET 280 ENGINEERED MUTATION SEQRES 1 A 272 GLY PRO LEU GLY SER LYS ARG GLN TRP THR LEU GLU ASP SEQRES 2 A 272 PHE ASP ILE GLY ARG PRO LEU GLY LYS GLY LYS PHE GLY SEQRES 3 A 272 ASN VAL TYR LEU ALA ARG GLU ARG GLN SER LYS PHE ILE SEQRES 4 A 272 LEU ALA LEU LYS VAL LEU PHE LYS THR GLN LEU GLU LYS SEQRES 5 A 272 ALA GLY VAL GLU HIS GLN LEU ARG ARG GLU VAL GLU ILE SEQRES 6 A 272 GLN SER HIS LEU ARG HIS PRO ASN ILE LEU ARG LEU TYR SEQRES 7 A 272 GLY TYR PHE HIS ASP ALA THR ARG VAL TYR LEU ILE LEU SEQRES 8 A 272 GLU TYR ALA PRO LEU GLY THR VAL TYR ARG GLU LEU GLN SEQRES 9 A 272 LYS LEU SER ARG PHE ASP GLU GLN ARG THR ALA THR TYR SEQRES 10 A 272 ILE THR GLU LEU ALA ASN ALA LEU SER TYR CYS HIS SER SEQRES 11 A 272 LYS ARG VAL ILE HIS ARG ASP ILE LYS PRO GLU ASN LEU SEQRES 12 A 272 LEU LEU GLY SER ASN GLY GLU LEU LYS ILE ALA ASP PHE SEQRES 13 A 272 GLY TRP SER VAL HIS ALA PRO SER SER ARG ARG THR THR SEQRES 14 A 272 LEU CYS GLY THR LEU ASP TYR LEU PRO PRO GLU MET ILE SEQRES 15 A 272 GLU GLY ARG MET HIS ASP GLU LYS VAL ASP LEU TRP SER SEQRES 16 A 272 LEU GLY VAL LEU CYS TYR GLU PHE LEU VAL GLY MET PRO SEQRES 17 A 272 PRO PHE GLU ALA HIS THR TYR GLN GLU THR TYR ARG ARG SEQRES 18 A 272 ILE SER ARG VAL GLU PHE THR PHE PRO ASP PHE VAL THR SEQRES 19 A 272 GLU GLY ALA ARG ASP LEU ILE SER ARG LEU LEU LYS HIS SEQRES 20 A 272 ASN ALA SER GLN ARG LEU THR LEU ALA GLU VAL LEU GLU SEQRES 21 A 272 HIS PRO TRP ILE LYS ALA ASN SER SER LYS PRO SER HET AK5 A 1 31 HETNAM AK5 3-({3-[(6-AMINO-5-BROMOPYRIMIDIN-4-YL) HETNAM 2 AK5 SULFANYL]PROPANOYL}AMINO)-4-METHOXY-N-PHENYLBENZAMIDE FORMUL 2 AK5 C21 H20 BR N5 O3 S FORMUL 3 HOH *369(H2 O) HELIX 1 1 THR A 142 GLU A 144 5 3 HELIX 2 2 GLY A 153 LYS A 156 5 4 HELIX 3 3 LYS A 179 GLY A 186 1 8 HELIX 4 4 VAL A 187 SER A 199 1 13 HELIX 5 5 THR A 230 SER A 239 1 10 HELIX 6 6 ASP A 242 LYS A 263 1 22 HELIX 7 7 LYS A 271 GLU A 273 5 3 HELIX 8 8 THR A 305 LEU A 309 5 5 HELIX 9 9 PRO A 310 GLU A 315 1 6 HELIX 10 10 ASP A 320 GLY A 338 1 19 HELIX 11 11 THR A 346 VAL A 357 1 12 HELIX 12 12 THR A 366 LEU A 377 1 12 HELIX 13 13 ASN A 380 ARG A 384 5 5 HELIX 14 14 THR A 386 GLU A 392 1 7 HELIX 15 15 HIS A 393 SER A 400 1 8 SHEET 1 A 5 PHE A 146 PRO A 151 0 SHEET 2 A 5 ASN A 159 GLU A 165 -1 O LEU A 162 N GLY A 149 SHEET 3 A 5 ILE A 171 PHE A 178 -1 O VAL A 176 N ASN A 159 SHEET 4 A 5 ARG A 218 LEU A 223 -1 O LEU A 223 N ALA A 173 SHEET 5 A 5 LEU A 209 HIS A 214 -1 N PHE A 213 O TYR A 220 SHEET 1 B 2 LEU A 275 LEU A 277 0 SHEET 2 B 2 LEU A 283 ILE A 285 -1 O LYS A 284 N LEU A 276 SITE 1 AC1 11 PHE A 157 LYS A 175 LEU A 191 GLN A 198 SITE 2 AC1 11 LEU A 207 LEU A 223 GLU A 224 ALA A 226 SITE 3 AC1 11 PHE A 288 GLY A 289 HOH A 427 CRYST1 97.738 97.738 62.224 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010231 0.005907 0.000000 0.00000 SCALE2 0.000000 0.011814 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016071 0.00000